Issue Brief
  1. As of October 8, 2019, virtually all of the 12 Democratic presidential candidates appearing in the October 15, 2019 debate have expressed support for Medicare drug price negotiation, based on a review of their 2020 campaign websites and sponsorship or co-sponsorship of legislation introduced in the 116th Congress.

    ← Return to text

  2. Senator Klobuchar is also a co-sponsor of S. 377, Medicare Negotiation and Competitive Licensing Act of 2019.

    ← Return to text

  3. Kapczynski, A., and Kesselheim, A.S. ‘Government patent use’: A legal approach to reducing drug spending. Health Affairs, 35(5), 2016; Rizvi, Z., Kapczynski, A., and Kesselheim, A.S. “A simple way for the government to curb inflated drug prices.” The Washington Post, May 12, 2016; Zaitchik, A. “How the government can bring down drug prices,” American Prospect, June 29, 2017; Lee, J. “Can an obscure, 100-year-old patent law take on big pharma?” Bloomberg, May 21, 2018; “How the government can lower drug prices [Editorial]” The New York Times, June 20, 2018.

    ← Return to text

Appendix
  1. Kapczynski and Kesselheim, 2016; Rizvi, Kapczynski, and Kesselheim, 2016; Zaitchik, 2017; Lee, 2018; How the government can lower drug prices [Editorial]. The New York Times, June 20, 2018.

    ← Return to text

  2. Kapczynski and Kesselheim, 2016; Zaitchik, 2017.

    ← Return to text

  3. Brennan, H., Kapczynski, A., and Monahan, C.H. “A prescription for excessive drug pricing: Leveraging government patent use for health.” Yale Journal of Law and Technology, 18(1), 275-354, 2017; Bruns, B.S. The Pharmaceutical Access Act: An administrative eminent domain solution to high drug prices. California Law Review, 106(6), 2023-2066, 2018; KEIWashDC. (2017, April 19). Feb. 24, 2017 compulsory licensing workshop - panel discussion, 28 U.S.C. 1498 [Video file], available at http://www.youtube.com/watch?v=Za9RbL0jtds.

    ← Return to text

  4. How the government can lower drug prices [Editorial]. The New York Times, June 20, 2018.

    ← Return to text

  5. Lee, 2018; How the government can lower drug prices [Editorial]. The New York Times, June 20, 2018.

    ← Return to text

  6. Kapczynski and Kesselheim, 2016; Rizvi, Kapczynski, and Kesselheim, 2016; Zaitchik, 2017; Hepatitis C: Louisiana’s plan to increase access to treatment [Amicus]. Harvard Civil Rights-Liberties Law Review, 2017.

    ← Return to text

  7. Hepatitis C: Louisiana’s plan to increase access to treatment [Amicus], 2017; Johnson, C.Y. “Louisiana considers radical step to counter high drug prices: Federal intervention.” The Washington Post, July 3, 2017.

    ← Return to text

  8. Thomas, J.R. March-in rights under the Bayh-Dole Act, CRS Report No. R44597, Congressional Research Service, 2016.

    ← Return to text

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.